Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ALRV5XR is a multi-component botanical treatment regimen developed by Arbor Life Labs for the management of androgenetic alopecia (AGA) and telogen effluvium (TE). The regimen is a multi-molecular targeting system comprising an oral dietary supplement, a shampoo, a conditioner, and a topical follicle serum. It is designed to promote hair regrowth by activating hair follicle stem cells and modulating various molecular pathways associated with the hair growth cycle. Clinical data from randomized, double-blind, placebo-controlled trials in both men and women indicate that ALRV5XR significantly increases terminal hair density and improves the terminal-to-vellus hair ratio. Unlike some conventional treatments that show plateauing effects, ALRV5XR has demonstrated linear or accelerating regrowth profiles over 24 weeks of treatment and is reported to be well-tolerated with no significant adverse events.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ALRV5XR.